Your browser doesn't support javascript.
loading
Linking early-life bilingualism and cognitive advantage in older adulthood.
Ballarini, Tommaso; Kuhn, Elizabeth; Röske, Sandra; Altenstein, Slawek; Bartels, Claudia; Buchholz, Friederike; Buerger, Katharina; Dechent, Peter; Dobisch, Laura; Ewers, Michael; Fliessbach, Klaus; Freiesleben, Silka Dawn; Frommann, Ingo; Gabelin, Tatjana; Glanz, Wenzel; Görß, Doreen; Haynes, John Dylan; Incesoy, Enise I; Janowitz, Daniel; Kilimann, Ingo; Kleineidam, Luca; Kobeleva, Xenia; Laske, Christoph; Lohse, Andrea; Maier, Franziska; Munk, Matthias H; Perneczky, Robert; Peters, Oliver; Priller, Josef; Rauchmann, Boris-Stephan; Roy, Nina; Scheffler, Klaus; Schneider, Anja; Schott, Björn H; Spottke, Annika; Spruth, Eike Jakob; Teipel, Stefan; Wiltfang, Jens; Wolfsgruber, Steffen; Düzel, Emrah; Jessen, Frank; Wagner, Michael.
Afiliação
  • Ballarini T; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. Electronic address: tommaso.ballarini@dzne.de.
  • Kuhn E; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Röske S; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Altenstein S; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.
  • Bartels C; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany.
  • Buchholz F; Department of Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Buerger K; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU, Munich, Germany.
  • Dechent P; MR-Research in Neurosciences, Department of Cognitive Neurology, Georg-August-University Goettingen, Goettingen, Germany.
  • Dobisch L; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany; Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.
  • Ewers M; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU, Munich, Germany.
  • Fliessbach K; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, University of Bonn Medical Center, Bonn, Germany.
  • Freiesleben SD; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Frommann I; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, University of Bonn Medical Center, Bonn, Germany.
  • Gabelin T; Department of Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Glanz W; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Görß D; Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany.
  • Haynes JD; Bernstein Center for Computational Neuroscience, Charité - Universitätsmedizin, Berlin, Germany.
  • Incesoy EI; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.
  • Janowitz D; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU, Munich, Germany.
  • Kilimann I; Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany; German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
  • Kleineidam L; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Kobeleva X; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Laske C; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
  • Lohse A; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.
  • Maier F; Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany.
  • Munk MH; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany; Section for Dementia Research, Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen, Tübingen, Germany.
  • Perneczky R; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Department of Psychiatry and Psychotherapy, University Hospital, LMU, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany; Ageing Epidemiology Research Unit (AGE), School of Public Health, Imperial Col
  • Peters O; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Psychiatry, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Priller J; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany; Department of Psychiatry and Psychotherapy, School of Medicine, Technical University of Munich, Munich, Germany; University of Edinburgh and UK DRI, Edinburgh,
  • Rauchmann BS; Department of Psychiatry and Psychotherapy, University Hospital, LMU, Munich, Germany.
  • Roy N; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
  • Scheffler K; Department for Biomedical Magnetic Resonance, University of Tübingen, Tübingen, Germany.
  • Schneider A; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, University of Bonn Medical Center, Bonn, Germany.
  • Schott BH; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany; Leibniz Institute for Neurobiology, Magdeburg, Germany.
  • Spottke A; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurology, University of Bonn, Bonn, Germany.
  • Spruth EJ; German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany; Department of Psychiatry and Psychotherapy, Charité, Berlin, Germany.
  • Teipel S; Department of Psychosomatic Medicine, Rostock University Medical Center, Rostock, Germany; German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany.
  • Wiltfang J; Department of Psychiatry and Psychotherapy, University Medical Center Goettingen, University of Goettingen, Goettingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Goettingen, Germany; Department of Medical Sciences, Neurosciences and Signaling Group, Institute of Biomedicine (iBiM
  • Wolfsgruber S; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, University of Bonn Medical Center, Bonn, Germany.
  • Düzel E; German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany; Institute of Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University, Magdeburg, Germany.
  • Jessen F; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Psychiatry, Medical Faculty, University of Cologne, Cologne, Germany; Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
  • Wagner M; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany; Department of Neurodegenerative Disease and Geriatric Psychiatry/Psychiatry, University of Bonn Medical Center, Bonn, Germany.
Neurobiol Aging ; 124: 18-28, 2023 04.
Article em En | MEDLINE | ID: mdl-36706574
ABSTRACT
Previous studies have identified bilingualism as a protective factor against dementia. Here we aimed to test whether being bilingual at different life stages impacts cognition and brain structure in older adulthood. We included 746 participants from the DZNE-Longitudinal Cognitive Impairment and Dementia Study (DELCODE). Assessment of bilingualism at 3 life stages (early 13-30, middle 30-65 and late over 65 years old) was determined with the Lifetime of Experiences Questionnaire. Individuals reporting bilingualism (i.e., daily use of L2) in the early life stage outperformed monolinguals on learning & memory, working-memory, executive functions and language. Bilingualism in middle life stage showed a significant advantage on learning & memory, while no effect of bilingualism in old life stage was identified. Brain gray matter volume was not associated with L2 use and did not differ between groups. However, stronger correlations between brain gray matter volume in selected brain regions and cognitive performance were found in bilingual participants in the early and middle life stages. Our results indicate that bilingualism in early life might provide a long-lasting protective effect on cognition and shape the brain to sustain cognitive performance in older adulthood.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Multilinguismo / Demência Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Neurobiol Aging Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Multilinguismo / Demência Tipo de estudo: Prognostic_studies Limite: Aged / Humans Idioma: En Revista: Neurobiol Aging Ano de publicação: 2023 Tipo de documento: Article